Neurotrack

#Medicare "cognitive assessment and care plan services" usage tripled from 2018 to 2022, but only 2.4% of Alzheimer's-diagnosed beneficiaries accessed these crucial services in 2021. 🤔@Neurotrack's workflow-friendly cognitive screening tools support utilization.
🧠💙

Upbeat weekend read on palpable optimism at the @CTADconference from @Bloomberg reporters @RobertLangreth  and Gerry Smith. Promising drug news from @EisaiUS, @EliLillyandCo , @biogen, and @Roche, too: bit.ly/3Qgs8Ox

Jaw-dropping stats from USC, but we have a solution. Neurotrack's digital screener identifies cognitive impairment in as little as 3 minutes. Our FDA-registered, first-of-its-kind tool has been in clinical use for a year with major health delivery orgs. @haleysweiss

DYK: Up to 2/3 of women notice cognitive changes in menopause & brain fog is the #2 complaint of women at virtual clinic @midihealth. Our @ellikaplan stopped by the @CoolFlashes pod to talk women's brain health. Give it a listen for #WorldMenopauseDay: go.neurotrack.io/wmd

See you at #HLTH2023! Try our cognitive screening tool, enter a prize drawing, and more at Neurotrack's kiosk in the MATTER Pavilion. Visit the Sky Stage on Sunday at 2:50 where @ellikaplan will discuss the progress we're making in #Alzheimers & other neurodegenerative disease.